Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma
Medicina · 17.05.2026 · 62 (5) · 981
DOI: 10.3390/medicina62050981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, online erschienen am 17.05.2026. Verfasst von Aydan Farzaliyeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Baskent University, 06490 Ankara, Türkiye. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Neoplasm Recurrence, Local. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Papillary thyroid microcarcinoma (PTMC) is generally indolent; however, a subset exhibits aggressive features, reflecting biological heterogeneity. In the era of treatment de-escalation and active surveillance, accurate risk stratification is essential. We aimed to evaluate recurrence, identify factors associated with recurrence, determine predictors of lymph node metastasis (LNM) at diagnosis, and assess management strategies at our center. Materials and Methods: This retrospective study included 302 patients with PTMC. Associations between clinicopathological variables and outcomes were evaluated using chi-square test, Spearman correlation, and univariate and multivariate logistic regression analyses.
Results
The cohort included 240 females (79.5%) and 62 males (20.5%), with a median age of 47 years. Total thyroidectomy was performed in 97.7%, and radioactive iodine (RAI) in 64.2%. LNM was identified in 26 patients (8.6%). Recurrence occurred in 4 patients (1.3%), and 98.0% were alive at last follow-up. Recurrence was associated with LNM at diagnosis, higher ATA risk categories, and positive surgical margins (p < 0.005). Younger age, larger tumor size, and vascular invasion independently predicted LNM (all p < 0.05), while autoimmune thyroiditis was associated with a reduced risk (p = 0.020).
Conclusions
PTMC demonstrates clinically relevant heterogeneity, particularly in patients with LNM. However, given the limited number of recurrence events, recurrence-related findings should be interpreted cautiously and considered exploratory. These findings support risk-adapted management and careful patient selection in the era of treatment de-escalation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Faculty of Medicine, Baskent University, 06490 Ankara, Türkiye.
- Department of Endocrinology and Metabolic Diseases, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye.
- Department of Endocrinology and Metabolic Diseases, Faculty of Medicine, Baskent University, 06490 Ankara, Türkiye.
ORCID-Profile: Aydan Farzaliyeva, Feride Pınar Altay, Ozlem Turhan Iyidir
Zitieren
APA
Farzaliyeva, A., Altay, F. P., Turhan Iyidir, O., & Bascil Tutuncu, N. (2026). Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma. Medicina, 62(5), 981. https://doi.org/10.3390/medicina62050981
Vancouver
Farzaliyeva A, Altay FP, Turhan Iyidir O, Bascil Tutuncu N. Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma. Medicina. 2026;62(5):981. doi:10.3390/medicina62050981
BibTeX
@article{Farzaliyeva2026,
author = {Farzaliyeva, Aydan and Altay, Feride Pınar and Turhan Iyidir, Ozlem and Bascil Tutuncu, Neslihan},
title = {Prognostic Factors and Recurrence in Papillary Thyroid Microcarcinoma},
journal = {Medicina},
year = {2026},
volume = {62},
number = {5},
pages = {981},
doi = {10.3390/medicina62050981}
}
EUVIMED